On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2

The current epidemic of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) calls for the development of inhibitors of viral replication. Here, we performed a bioinformatic analysis of published and purported SARS-CoV-2 antivirals including imatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauvat, Allan, Ciccosanti, Fabiola, Colavita, Francesca, Di Rienzo, Martina, Castilletti, Concetta, Capobianchi, Maria Rosaria, Kepp, Oliver, Zitvogel, Laurence, Fimia, Gian Maria, Piacentini, Mauro, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434849/
https://www.ncbi.nlm.nih.gov/pubmed/32814759
http://dx.doi.org/10.1038/s41419-020-02842-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434849/
https://www.ncbi.nlm.nih.gov/pubmed/32814759
http://dx.doi.org/10.1038/s41419-020-02842-x

Ejemplares similares